@article{2e62098c44ef4e99b41e42f844543dfe,
title = "Phase I trial of vorinostat combined with bevacizumab and CPT-11 in recurrent glioblastoma",
author = "Prakash Chinnaiyan and Sajeel Chowdhary and Lisa Potthast and Antony Prabhu and Tsai, \{Ya Yu\} and Bhaswati Sarcar and Soumen Kahali and Steven Brem and Yu, \{H. Michael\} and Amyn Rojiani and Ryan Murtagh and Edward Pan",
note = "Each year, >14 000 new cases of malignant gliomas are diagnosed in the United States, with the most aggressive form, glioblastoma, being the most common. Despite comprehensive, multimodality treatment consisting of surgery, radiation therapy, and chemotherapy, prognosis remains poor, with a majority of patients developing disease recurrence within months after definitive therapy.",
year = "2012",
month = jan,
day = "1",
doi = "10.1093/NEUONC/NOR187",
language = "American English",
volume = "14",
journal = "Neuro-oncology",
}